Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Assets: 2009-2024

Historic Assets for Fresenius Medical Care AG (FMS) over the last 17 years, with Sep 2025 value amounting to $36.1 billion.

  • Fresenius Medical Care AG's Assets rose 1.13% to $36.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $141.8 billion, marking a year-over-year decrease of 2.86%. This contributed to the annual value of $35.9 billion for FY2024, which is 2.27% down from last year.
  • According to the latest figures from Q3 2025, Fresenius Medical Care AG's Assets is $36.1 billion, which was up 1.94% from $35.4 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Assets registered a high of $40.0 billion during Q1 2021, and its lowest value of $58.0 million during Q4 2021.
  • Over the past 3 years, Fresenius Medical Care AG's median Assets value was $36.5 billion (recorded in 2024), while the average stood at $36.6 billion.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Assets tumbled by 74.21% in 2021, and later surged by 62,819.95% in 2022.
  • MRQ analysis of 5 years shows Fresenius Medical Care AG's Assets stood at $58.0 million in 2021, then soared by 62,819.95% to $36.5 billion in 2022, then increased by 0.08% to $36.5 billion in 2023, then fell by 1.75% to $35.9 billion in 2024, then increased by 0.67% to $36.1 billion in 2025.
  • Its Assets stands at $36.1 billion for Q3 2025, versus $35.4 billion for Q2 2025 and $34.4 billion for Q1 2025.